AI enhances physicians’ ability to identify extent of prostate cancer with 84% accuracy

City of Hope deploys HopeLLM: AI platform transforms clinical workflows and patient care

City of Hope has developed and deployed HopeLLM, a proprietary generative AI platform that addresses critical operational challenges in hospitals while advancing personalized cancer care.

CancerLinQ receives ASCO-certified RQS status

Concert AI’s CancerLinQ initiative has received ASCO’s Recognized Quality Solution status—a recognition that positions the platform as a validated gateway for partnered oncology practices into ASCO’s flagship certification program.

September 05, 2025

Vol.51 No.32

Clinical Roundup

Decipher Prostate Test predicts chemo benefit in metastatic prostate cancer, phase III trial shows

The Decipher Prostate Genomic Classifier predicts which patients with metastatic cancer are likely to benefit from treatment intensification with the chemotherapy docetaxel and which are not likely to benefit and can therefore avoid unnecessary toxicity, according to findings by University College London and Veracyte, Inc., a genomic diagnostic company.

September 05, 2025

Vol.51 No.32

Clinical Roundup

Many patients with advanced cancer feel treatment not aligned with personal care goals, UC study shows

Many people with advanced cancer report that their treatment does not align with their personal care goals, according to a study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center and the UCLA Palliative Care Research Center.

September 05, 2025

Vol.51 No.32

Clinical Roundup

Mailing at-home test kits is more effective at getting younger adults to participate in CRC screening, UCLA study finds

Mailing a stool-based test directly to people’s homes was the most effective of four strategies for increasing colorectal cancer screening rates, according to a study by UCLA researchers aimed at identifying the best approach to promote CRC screening in adults ages 45 to 49.

August 08, 2025

Vol.51 No.31

In Brief

UIC, Northwestern, Moffitt researchers awarded $1.2M DOD grant for prostate cancer research

The U.S. Department of Defense Prostate Cancer Research Program has awarded the Data Science Award and a $1.2 million grant to researchers Charles Gaber, Natalie Reizine, Todd Lee, Lucia Petito, and Jessica Islam.

August 01, 2025

Vol.51 No.30

AI enhances physicians’ ability to identify extent of prostate cancer with 84% accuracy

YOU MAY BE INTERESTED IN

City of Hope deploys HopeLLM: AI platform transforms clinical workflows and patient care

CancerLinQ receives ASCO-certified RQS status

Decipher Prostate Test predicts chemo benefit in metastatic prostate cancer, phase III trial shows

Many patients with advanced cancer feel treatment not aligned with personal care goals, UC study shows

Mailing at-home test kits is more effective at getting younger adults to participate in CRC screening, UCLA study finds

UIC, Northwestern, Moffitt researchers awarded $1.2M DOD grant for prostate cancer research

Renew today!

Subscriber content

Never miss an issue!

Login